A prognostic index for operable, node-negative breast cancer

Clinical data and samples from patients diagnosed, more than 10 years previously, with operable node-negative breast cancer (participants in the Scottish Adjuvant Tamoxifen trial), were revisited. Cases with two distinct categories of outcome were selected; more than 10 years disease-free survival (...

Descripción completa

Detalles Bibliográficos
Autores principales: McCallum, M, Baker, C, Gillespie, K, Cohen, B, Stewart, H, Leonard, R, Cameron, D, Leake, R, Paxton, J, Robertson, A, Purdie, C, Gould, A, Steel, M
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2004
Materias:
Molecular and Cellular Pathology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2409476/
https://www.ncbi.nlm.nih.gov/pubmed/15138474
http://dx.doi.org/10.1038/sj.bjc.6601826

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2409476/
https://www.ncbi.nlm.nih.gov/pubmed/15138474
http://dx.doi.org/10.1038/sj.bjc.6601826

Ejemplares similares